03.07.2014
- With effect from July 1, German chemical and pharmaceutical producer Merck KGaA acquired all of the capital of its long-standing cooperation partner, Dutch start-up Peer+ for an...
26.06.2014
- In what it called the largest corporate euro hybrid bond transaction worldwide, Bayer has issued two hybrid bonds with a total volume of €3.25 billion as the first step in...
25.06.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, and US company Mersana Therapeutics, based in Cambridge, Massachusetts, have agreed to collaborate on...
17.06.2014
- German chemical and pharmaceutical producer Merck has agreed to sell the laboratory equipment and production units of Chemische Fabrik Lehrte to compatriot Schüssler Novachem, a...
13.06.2014
- Germany's Merck and compatriot biotech firm MorphoSys have agreed to cooperate on discovering and developing therapeutic antibodies against undisclosed immune checkpoints, that is...
10.06.2014
- Merck & Co has announced it will buy Idenix Pharmaceuticals for $3.85 billion. The US drugmaker plans to combine the most promising drugs in the two portfolios to produce a faster...
04.06.2014
- If Matthias Zachert mounted the steep steps to the new Lanxess headquarters on the Rhine River in Cologne, when returning to the German chemical producer as CEO on April l, he may...
22.05.2014
- German chemicals and pharmaceuticals producer Merck KGaA is participating in a new €2 million project sponsored by the country's research ministry, aimed at developing a fully...
